SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant fungal infections.

Biotechnology

SCYNEXIS

David Angulo

Michelle Middle

Astra Sparks

Christopher Anastasi

Sumit Kumar

Philip Deane

Lori Tierney

Lindsay Muller

Rossana Ferrara-Pontoriero

Lawrence R. Hoffman

Daniella Gigante

Ivor Macleod

Scott Sukenick

The leadership team at SCYNEXIS has a long history of experience in the biotech industry, with members having served as vice presidents, directors, and attorneys for various companies. They also have a wide range of educational backgrounds, including degrees in infectious diseases, life sciences, and law.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at SCYNEXIS

Board of Directors

CEO and Executive Team